Work

Abstract 4291: Synecta™ T1 cell-derived nanoparticles enable accelerated, potent T cell expansion for scalable adoptive immunotherapy manufacturing

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-4291

Authors: Deeksha Muthumani, Chiquita Hanindya, Gil Joseph, Victor Carpio, Bakir Valentić, Roddy O' Connor, Olga Barreiro, Ulrich H. Von Andrian, Peter Keller

Institutions: University of Pennsylvania, Harvard University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148801848

Cites:

Cited by:

Related to: